Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

1-(2'-Deoxy-2'-[18F]fluoroarabinofuranosyl)cytosine

In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004.
[updated ].
Affiliations
Free Books & Documents
Review

1-(2'-Deoxy-2'-[18F]fluoroarabinofuranosyl)cytosine

Kam Leung.
Free Books & Documents

Excerpt

One of the characteristics of tumor cells is their unchecked proliferation. It is important to measure the proliferation rate of cancer lesions to help differentiate benign tumors from malignant tumors and to characterize malignant tumors among normal tissues. 2-[18F]Fluoro-2-deoxy-d-glucose ([18F]FDG) has been approved for cancer positron emission tomography (PET) imaging by the United States Food and Drug Administration. However, enhanced uptake of FDG as measurement of glycolysis occurs in inflammatory cells and lesions as well as in necrotic cells (1, 2). Thymidine (TdR) and TdR analogs are the standard markers for DNA synthesis, and [11C]TdR has been used in PET to measure tumor growth rates in situ. Because of the short half-life of 11C and the extensive metabolism of [11C]TdR in the blood (3), 3'-deoxy-3'-[18F]fluorothymidine (FLT) was developed for PET imaging. FLT is an analog of TdR and is phosphorylated by TdR kinase-1 (TK-1), an enzyme expressed during the DNA synthesis phase (S-phase) of the cell cycle (4). On the other hand, RNA synthesis occurs in all phases of the cell cycle except the M phase, even in slow-growing solid tumors. Tracers targeted to RNA synthesis could be used to visualize tumors with low TK-1 expression.

Phosphorylation of deoxyribonucleosides and their nucleoside analogs is carried out with deoxycytidine kinase (DCK) (5). DCK is ubiquitously expressed in normal tissues but is highly expressed in hematolymphoid tissues (spleen, thymus, and lymph nodes) and epithelial cells (6). Lymphoid cells and rapidly proliferating cells prefer the salvage pathway over the de novo pathway for DNA synthesis. 1-(2'-Deoxy-2'-fluoroarabinofuranosyl)cytosine (FAC) was found to be retained in proliferating T cells. FAC is taken up by cells and rapidly phosphorylated by DCK and trapped inside the cells. In this chapter, 1-(2'-deoxy-2'-[18F]fluoroarabinofuranosyl)cytosine ([18F]FAC) is being developed as a PET probe for imaging of epithelium, lymphoid tissues, and immune activation (6-8).

PubMed Disclaimer

Similar articles

  • 3'-(E)-(2-[123/131I]Iodovinyl)uridine.
    Leung K. Leung K. 2010 Mar 17 [updated 2010 Apr 22]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 Mar 17 [updated 2010 Apr 22]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641989 Free Books & Documents. Review.
  • 3'-Deoxy-3'-[18F]fluorothymidine.
    Leung K. Leung K. 2004 Oct 1 [updated 2005 Jan 15]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2004 Oct 1 [updated 2005 Jan 15]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641574 Free Books & Documents. Review.
  • Stratification of nucleoside analog chemotherapy using 1-(2'-deoxy-2'-18F-fluoro-β-D-arabinofuranosyl)cytosine and 1-(2'-deoxy-2'-18F-fluoro-β-L-arabinofuranosyl)-5-methylcytosine PET.
    Lee JT, Campbell DO, Satyamurthy N, Czernin J, Radu CG. Lee JT, et al. J Nucl Med. 2012 Feb;53(2):275-80. doi: 10.2967/jnumed.111.090407. J Nucl Med. 2012. PMID: 22302964 Free PMC article.
  • 1-(2’-Deoxy-2’-[18F]-fluoro-β-D-arabinofuranosyl)thymine.
    Chopra A. Chopra A. 2008 Jan 9 [updated 2008 Feb 14]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2008 Jan 9 [updated 2008 Feb 14]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641443 Free Books & Documents. Review.
  • 2’-Fluoro-5-([11C]-methyl)-1-β-D-arabinofuranosyluracil.
    Chopra A. Chopra A. 2008 Jan 2 [updated 2008 Jan 24]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2008 Jan 2 [updated 2008 Jan 24]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641855 Free Books & Documents. Review.

References

    1. Kubota R., Yamada S., Kubota K., Ishiwata K., Tamahashi N., Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. . J Nucl Med. 1992;33(11):1972–80. - PubMed
    1. van Waarde A., Cobben D.C., Suurmeijer A.J., Maas B., Vaalburg W., de Vries E.F., Jager P.L., Hoekstra H.J., Elsinga P.H. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model. . J Nucl Med. 2004;45(4):695–700. - PubMed
    1. Ishiwata K., Ido T., Abe Y., Matsuzawa T., Murakami M. Studies on 18F-labeled pyrimidines III. Biochemical investigation of 18F-labeled pyrimidines and comparison with 3H-deoxythymidine in tumor-bearing rats and mice. . Eur J Nucl Med. 1985;10(1-2):39–44. - PubMed
    1. Sherley J.L., Kelly T.J. Regulation of human thymidine kinase during the cell cycle. . J Biol Chem. 1988;263(17):8350–8. - PubMed
    1. Arner E.S., Eriksson S. Mammalian deoxyribonucleoside kinases. . Pharmacol Ther. 1995;67(2):155–86. - PubMed

LinkOut - more resources